|
|
||||||||
Articles |
To address whether gonadotropin-releasing hormone (GnRH) regulates its own expression and the expression of its receptor in the hypothalamus and ovary, we treated five groups of prepubertal/peripubertal female rats from postnatal days 25-36 with either the GnRH agonist triptorelin (TRIP) or the GnRH antagonist cetrorelix (CET), each 10 or 100 microgram/day, or a placebo. We compared their effects regarding pubertal development, serum gonadotropins and the expression of GnRH and GnRH-receptor in the hypothalamus, pituitary, ovary and uterus. Onset of puberty was determined by vaginal opening, and expression levels of GnRH and GnRH-receptor were determined using either quantitative real-time PCR or competitive RT-PCR. Onset of puberty was retarded by both analogs but CET (100 microgram/day) inhibited while TRIP (10 and 100 microgram/day) stimulated serum gonadotropins (P<0.05). The expression of GnRH in the preoptic area did not show significant differences among the treatment groups but ovarian GnRH mRNA levels were significantly stimulated by CET (100 microgram/day). GnRH mRNA could not be detected in the uterus by either real-time PCR or competetive RT-PCR. The GnRH-receptor expression in the hypothalamus (preoptic area and mediobasal hypothalamus) did not vary among any of the groups, whereas in the pituitary GnRH-receptor mRNA levels were stimulated by TRIP (10 microgram/day) but inhibited by CET (100 microgram/day). In contrast, in the ovary GnRH-receptor mRNA levels were inhibited by both TRIP (100 microgram/day) and CET (100 microgram/day). Interestingly, the GnRH-receptor was even expressed in the uterus where it was strongly stimulated by both CET and TRIP in a dose-related manner. This shows that in addition to their different pituitary effects, the GnRH analogs cetrorelix and triptorelin exert different actions at the hypothalamic, ovarian and uterine level. This study also demonstrates an organ-specific regulation of GnRH and GnRH-receptor gene expression which is likely part of a local autoregulatory system. We conclude that the ovarian and uterine effects of GnRH analogs must be considered in addition to their known pituitary effects when deciding which GnRH analog is most suitable for treating precocious puberty.
This article has been cited by other articles:
![]() |
J. Prange-Kiel, H. Jarry, M. Schoen, P. Kohlmann, C. Lohse, L. Zhou, and G. M. Rune Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesis J. Cell Biol., January 28, 2008; 180(2): 417 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Baldwin, I. N. Wegorzewska, M. Flora, and T. J. Wu Regulation of Type II Luteinizing Hormone-Releasing Hormone (LHRH-II) Gene Expression by the Processed Peptide of LHRH-I, LHRH-(1-5) in Endometrial Cells Experimental Biology and Medicine, January 1, 2007; 232(1): 146 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bottner, J. Christoffel, H. Jarry, and W. Wuttke Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats. J. Endocrinol., April 1, 2006; 189(1): 77 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Christoffel, G Rimoldi, and W Wuttke Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment. J. Endocrinol., March 1, 2006; 188(3): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Schirman-Hildesheim, T. Bar, N. Ben-Aroya, and Y. Koch Differential Gonadotropin-Releasing Hormone (GnRH) and GnRH Receptor Messenger Ribonucleic Acid Expression Patterns in Different Tissues of the Female Rat across the Estrous Cycle Endocrinology, August 1, 2005; 146(8): 3401 - 3408. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Wu, S. K. Mani, M. J. Glucksman, and J. L. Roberts Stimulation of Luteinizing Hormone-Releasing Hormone (LHRH) Gene Expression in GT1-7 Cells by Its Metabolite, LHRH-(1-5) Endocrinology, January 1, 2005; 146(1): 280 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A Herbert, T E Trigg, and D W Cooper Effect of deslorelin implants on follicular development, parturition and post-partum oestrus in the tammar wallaby (Macropus eugenii) Reproduction, February 1, 2004; 127(2): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zapatero-Caballero, F. Sanchez-Franco, C. Fernandez-Mendez, M. Garcia-San Frutos, L. M. Botella-Cubells, and G. Fernandez-Vazquez Gonadotropin-Releasing Hormone Receptor Gene Expression During Pubertal Development of Female Rats Biol Reprod, February 1, 2004; 70(2): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kovacs and A. V. Schally Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats PNAS, October 9, 2001; 98(21): 12197 - 12202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |